Vanguard Group’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$32.9M Buy
3,731,851
+144,712
+4% +$796K ﹤0.01% 2392
2025
Q3
$17.9M Buy
3,587,139
+14,336
+0.4% +$66.4K ﹤0.01% 2676
2025
Q2
$16.9M Buy
3,572,803
+77,519
+2% +$339K ﹤0.01% 2632
2025
Q1
$16M Sell
3,495,284
-11,003
-0.3% -$51.3K ﹤0.01% 2604
2024
Q4
$16.8M Sell
3,506,287
-125,002
-3% -$600K ﹤0.01% 2668
2024
Q3
$17M Buy
3,631,289
+199,618
+6% +$1.07M ﹤0.01% 2667
2024
Q2
$19.4M Buy
3,431,671
+36,088
+1% +$186K ﹤0.01% 2586
2024
Q1
$14M Sell
3,395,583
-60,504
-2% -$242K ﹤0.01% 2774
2023
Q4
$14.6M Sell
3,456,087
-19,205
-0.6% -$77.5K ﹤0.01% 2745
2023
Q3
$15M Sell
3,475,292
-762,144
-18% -$4.23M ﹤0.01% 2673
2023
Q2
$27.9M Buy
4,237,436
+109,322
+3% +$701K ﹤0.01% 2446
2023
Q1
$28M Buy
4,128,114
+135,948
+3% +$956K ﹤0.01% 2444
2022
Q4
$29.5M Buy
3,992,166
+97,612
+3% +$951K ﹤0.01% 2443
2022
Q3
$38.5M Buy
3,894,554
+56,822
+1% +$600K ﹤0.01% 2307
2022
Q2
$41.8M Buy
3,837,732
+61,891
+2% +$641K ﹤0.01% 2279
2022
Q1
$42.7M Sell
3,775,841
-100,843
-3% -$1.33M ﹤0.01% 2383
2021
Q4
$60.8M Sell
3,876,684
-109,444
-3% -$1.91M ﹤0.01% 2242
2021
Q3
$68.3M Sell
3,986,128
-109,950
-3% -$1.93M ﹤0.01% 2195
2021
Q2
$88.1M Buy
4,096,078
+60,594
+2% +$1.08M ﹤0.01% 2059
2021
Q1
$60.6M Buy
4,035,484
+76,404
+2% +$1.24M ﹤0.01% 2211
2020
Q4
$52M Buy
3,959,080
+28,139
+0.7% +$339K ﹤0.01% 2179
2020
Q3
$38M Sell
3,930,941
-372,716
-9% -$3.98M ﹤0.01% 2148
2020
Q2
$49.2M Sell
4,303,657
-125,258
-3% -$1.42M ﹤0.01% 2024
2020
Q1
$45.9M Sell
4,428,915
-31,868
-0.7% -$395K ﹤0.01% 1905
2019
Q4
$73.2M Buy
4,460,783
+152,077
+4% +$2.3M ﹤0.01% 1922
2019
Q3
$57.2M Buy
4,308,706
+698,365
+19% +$9.73M ﹤0.01% 2009
2019
Q2
$50.9M Sell
3,610,341
-381,391
-10% -$6.07M ﹤0.01% 2092
2019
Q1
$73.4M Sell
3,991,732
-172,780
-4% -$3.94M ﹤0.01% 1891
2018
Q4
$109M Buy
4,164,512
+194,558
+5% +$4.57M ﹤0.01% 1633
2018
Q3
$91.1M Buy
3,969,954
+629,086
+19% +$12.8M ﹤0.01% 1850
2018
Q2
$63.6M Buy
3,340,868
+202,308
+6% +$3.38M ﹤0.01% 2004
2018
Q1
$52.9M Buy
3,138,560
+307,933
+11% +$5.15M ﹤0.01% 2038
2017
Q4
$43M Buy
2,830,627
+56,260
+2% +$835K ﹤0.01% 2137
2017
Q3
$49.7M Buy
2,774,367
+93,472
+3% +$1.56M ﹤0.01% 2047
2017
Q2
$43.7M Buy
2,680,895
+186,548
+7% +$2.69M ﹤0.01% 2075
2017
Q1
$34.9M Buy
2,494,347
+521,669
+26% +$7.43M ﹤0.01% 2172
2016
Q4
$31.5M Buy
1,972,678
+307,264
+18% +$4.94M ﹤0.01% 2199
2016
Q3
$27.7M Buy
1,665,414
+56,479
+4% +$760K ﹤0.01% 2213
2016
Q2
$18M Buy
1,608,935
+12,657
+0.8% +$123K ﹤0.01% 2375
2016
Q1
$13.3M Buy
1,596,278
+111,350
+7% +$914K ﹤0.01% 2461
2015
Q4
$13.8M Buy
1,484,928
+23,797
+2% +$237K ﹤0.01% 2460
2015
Q3
$16.5M Buy
1,461,131
+79,375
+6% +$971K ﹤0.01% 2382
2015
Q2
$17.5M Buy
1,381,756
+133,070
+11% +$1.44M ﹤0.01% 2420
2015
Q1
$11.6M Buy
1,248,686
+68,159
+6% +$770K ﹤0.01% 2570
2014
Q4
$16.9M Buy
1,180,527
+127,441
+12% +$1.51M ﹤0.01% 2306
2014
Q3
$10.9M Buy
1,053,086
+36,353
+4% +$476K ﹤0.01% 2449
2014
Q2
$16.4M Buy
1,016,733
+14,391
+1% +$192K ﹤0.01% 2291
2014
Q1
$16.3M Buy
1,002,342
+58,443
+6% +$831K ﹤0.01% 2262
2013
Q4
$11.7M Buy
943,899
+42,337
+5% +$425K ﹤0.01% 2391
2013
Q3
$9.89M Buy
901,562
+117,291
+15% +$1.25M ﹤0.01% 2402
2013
Q2
$6.34M Buy
+784,271
New +$5.28M ﹤0.01% 2534

Other funds holding VNDA